4 Recruiting Acute Myeloid Leukemia Clinical Trials in Maryland
Explore active acute myeloid leukemia research studies enrolling across Maryland. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Acute Myeloid Leukemia Studies in Maryland
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML
📍 Greenebaum Cancer Center, University of Maryland Medical Systems — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
📍 Johns Hopkins University/Sidney Kimmel Cancer Center — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
📍 John Hopkins School of Medicine — Baltimore, Maryland
View Study & Checklist ➔